Maureen Bythrow

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

Perspectives on Daptomycin Resistance, with Emphasis on Resistance in Staphylococcus aureus

Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy

Update on prevalence and treatment of methicillin-resistantStaphylococcus aureusinfections

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Skeletal infections: microbial pathogenesis, immunity and clinical management

Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry

Actinomycosis: etiology, clinical features, diagnosis, treatment, and management

High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia

Proteomics and integrative omic approaches for understanding host–pathogen interactions and infectious diseases

Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

Mechanisms of Antibiotic Resistance

Actinomyces and Related Organisms in Human Infections

Lysosomal activity regulatesCaenorhabditis elegansmitochondrial dynamics through vitamin B12 metabolism

Antibiotics and Bacterial Resistance in the 21st Century

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa

Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa

Pseudo-Outbreak of Actinomyces graevenitzii Associated with Bronchoscopy

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa

2015 ESC Guidelines for the management of infective endocarditis

Antimicrobial Resistance in ESKAPE Pathogens

Diminished Susceptibility to Daptomycin Accompanied by Clinical Failure in a Patient With Methicillin-Resistant Staphylococcus aureus Bacteremia

Multicenter Evaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System for Identification of Gram-Positive Aerobic Bacteria

Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system

Assessment of Reproducibility of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Bacterial and Yeast Identification